The invention provides an immunogenic composition comprising: a) a conjugate that is a capsular saccharide from GBS serotype Ia conjugated to a carrier protein; b) a conjugate that is a capsular saccharide from GBS serotype Ib conjugated to a carrier protein; c) a conjugate that is a capsular saccharide from GBS serotype III conjugated to a carrier protein; d) a conjugate that is a capsular saccharide from GBS serotype II conjugated to a carrier protein; and e) a conjugate that is a capsular saccharide from GBS serotype V conjugated to a carrier protein.
申请公布号
AU2013326503(A9)
申请公布日期
2016.06.16
申请号
AU20130326503
申请日期
2013.10.03
申请人
NOVARTIS AG
发明人
GRANDI, GUIDO;MARGARIT Y ROS, IMMACULADA;MAIONE, DOMENICO